Clinical study on the treatment of acute pancreatitis with external application of Yi-Dan Therapy based on the method of“stagnation requiring dispersion”:study protocol for a randomized controlled trial  

作　　者：Pei-Xin Ge Bo-Yi Jia Nai-Wei Zhang Li-Bao An Qiao-Yan Zhang Yan-Mei Cai Xiao-Na Zhang Shao-Dong Hao Hong-Jie Cheng 

机构地区：[1]Third Affiliated Hospital of Beijing University of Chinese Medicine,Beijing,100029,China [2]Department of Gastrointestinal Disease,Fangshan Hospital,Beijing University of Chinese Medicine,Beijing 102488,China.

出　　处：《Gastroenterology & Hepatology Research》2024年第2期1-7,共7页胃肠与肝病学杂志（英文）

摘　　要：Background:Acute pancreatitis is an unpredictable and potentially lethal disease,causing tremendous pain in patients.The initial treatment of acute pancreatitis in modern medicine is supportive,but it is generally ineffective in relieving abdominal pain and distension.Traditional Chinese medicine has been shown to be more effective in regulating the body’s homeostasis and reducing the clinical symptoms of pancreatitis.Yi-Dan ointment,derived from Dahuang-Mudan Decoction,is an effective external ointment for treating acute pancreatitis.The aim of this trial is to investigate the clinical efficacy of Yi-Dan ointment,providing a valuable complement to existing treatment options for pancreatitis.Methods:This is a randomized controlled clinical trial with two parallel groups.Patients in the control group were given basic treatment and nursing for 7 days;in the treatment group,Yi-Dan ointment was applied externally in addition to basic treatment and nursing.The main indicator is the overall efficacy,serum amylase,acute physiology and chronic health evaluationⅡscore,symptom score,inflammatory markers,and classification of computed tomography.Conclusion:The trial results will provide high-quality evidence for Yi-Dan ointment,and provide a complement to existing treatment options for pancreatitis.

关 键 词：acute pancreatitis traditional Chinese medicine external treatment Yi-Dan ointment randomized controlled trial 

分 类 号：R57[医药卫生—消化系统]